Global Drug Delivery Technologies Market Analysis and Forecast Report 2030
$5000 – $10000
North American Drug Delivery Technologies Market by Route of Administration (Oral (Solid), Pulmonary (Nebulizer), Injectable (Device), Ocular (Device), Nasal (Drop), Topical (Solid), Implantable (Active)), End User (Hospital, Home Care) – Global Forecast to 2021
Description
Global Drug Delivery Technologies Market Analysis and Forecast Report 2030
Market Overview
CRI has released a report titled North American Drug Delivery Technologies Market – Analysis of Market Size, Share & Trends for 2014 – 2020 and Forecasts to 2031. The market is anticipated to reach USD xx billion by 2030 at CAGR of XX%. According to the report, emphasizes on the detailed understanding of some decisive factors such as size, share, sales, forecast trends, supply, production, demands, industry and CAGR in order to provide a comprehensive outlook of the global market
North American Drug Delivery Technologies Market Market: Key Players
Johnson & Johnson, Inc. (U.S.),
Merck & Co. Inc. (U.S.),
Novartis AG (Switzerland),
Bayer AG (Germany),
3M Company (U.S.),
F. Hoffmann-La Roche (Switzerland),
Becton, Dickinson and Company (U.S.),
GlaxoSmithKline (U.K.),
Pfizer, Inc. (U.S.), Antares Pharma (U.S.),
and Sanofi (France).
Segmentation
North American Drug Delivery Technologies Market, by Route of Administration
Oral Drug Delivery
Solid
Tablets
Capsules
Powders
Pills
Liquid
Solutions
Syrups
Semi-solid
Gels
Emulsions
Elixirs
Pulmonary Drug Delivery
Metered Dose Inhalers
Dry Powder Inhalers
Nebulizers
Jet Nebulizers
Ultrasonic Nebulizers
Soft Mist Nebulizers
Injectable Drug Delivery
Devices
Conventional Injectables
By Material
Glass Syringes
Plastic Syringes
By Product
Fillable Syringes
Prefilled Syringes
By Usability
Reusable Syringes
Disposable Syringes
Self-injectors
Needle-free Devices
Pen Injectors
Autoinjectors
Wearable Injectors
Other Devices
Formulations
Conventional Drug Delivery
Novel Drug Delivery
Long-acting Drug Delivery
Ocular Drug Delivery
Formulations
Liquid
Eye Drops
Liquid Sprays
Semi-solid
Gels
Ointments
Devices
Contact Lenses Coated with Drugs
Ocular Inserts
Nasal Drug Delivery
Nasal Drops
Nasal Sprays
Nasal Powders
Nasal Gels
Topical Drug Delivery
Liquid
Solutions
Suspensions
Semi-solid
Creams
Gels
Ointments
Lotions
Solid
Suppositories
Powders
Transdermal Drug Delivery
Transdermal Patches
Transdermal Gels
Implantable Drug Delivery
Active
Passive
Transmucosal Drug Delivery
Oral
Buccal
Sublingual
Other
Rectal
Vaginal
North American Drug Delivery Technologies Market, by End User
Hospitals
Home Care Settings
Ambulatory Surgical Centers/Clinics
Other End Users
North American Drug Delivery Technologies Market, by Country
U.S.
Canada
North American Drug Delivery Technologies Market Market Dynamics
North American Drug Delivery Technologies Market Market Size
Supply & Demand
Current Trends/Issues/Challenges
Competition & Companies Involved in the Market
Value Chain of the Market
Market Drivers and Restraints
The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:
COVID-19 pre and post business impact analysis
Detailed overview of the parent market
Changing market dynamics in the industry
In-depth market segmentation
What is the North American Drug Delivery Technologies Market Market growth?
Which segment accounted for the largest North American Drug Delivery Technologies Market Market share?
Who are the key players in the Griddles Market?
Historical, current and projected market size in terms of volume and value
Recent industry trends and developments
Competitive landscape
Strategies of key players and products offered
Potential and niche segments, geographical regions exhibiting promising growth
A neutral perspective on market performance
Must-have information for market players to sustain and enhance their market footprint
Note: Although care has been taken to maintain the highest levels of accuracy in CRI’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.
Table of Contents
Contents
1. Executive Summary
2. North American Drug Delivery Technologies Market
2.1. Product Overview
2.2. Market Definition
2.3. Segmentation
2.4. Assumptions and Acronyms
3. Research Methodology
3.1. Research Objectives
3.2. Primary Research
3.3. Secondary Research
3.4. Forecast Model
3.5. Market Size Estimation
4. Average Pricing Analysis
5. Macro-Economic Indicators
6. Market Dynamics
6.1. Growth Drivers
6.2. Restraints
6.3. Opportunity
6.4. Trends
7. Correlation & Regression Analysis
7.1. Correlation Matrix
7.2. Regression Matrix
8. Recent Development, Policies & Regulatory Landscape
9. Risk Analysis
9.1. Demand Risk Analysis
9.2. Supply Risk Analysis
10. North American Drug Delivery Technologies Market Analysis
10.1. Porters Five Forces
10.1.1. Threat of New Entrants
10.1.2. Bargaining Power of Suppliers
10.1.3. Threat of Substitutes
10.1.4. Rivalry
10.2. PEST Analysis
10.2.1. Political
10.2.2. Economic
10.2.3. Social
10.2.4. Technological
11. North American Drug Delivery Technologies Market
11.1. Market Size & forecast, 2020A-2030F
11.1.1. By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
11.1.2. By Volume (Million Units) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12. North American Drug Delivery Technologies Market: Market Segmentation
12.1. By Regions
12.1.1. North America:(U.S. and Canada), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.1.2. Latin America: (Brazil, Mexico, Argentina, Rest of Latin America), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.1.3. Europe: (Germany, UK, France, Italy, Spain, BENELUX, NORDIC, Hungary, Poland, Turkey, Russia, Rest of Europe), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.1.4. Asia-Pacific: (China, India, Japan, South Korea, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia Pacific), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.1.5. Middle East and Africa: (Israel, GCC, North Africa, South Africa, Rest of Middle East and Africa), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.2. By network type: Market Share (2020-2030F)
12.2.1. Hardware , By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.2.2. Software , By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.2.3. Services , By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3. By End user: Market Share (2020-2030F)
12.3.1. Manufacturing, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3.2. Healthcare, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3.3. Energy and Utilities, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3.4. IT & Telecom, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3.5. Automotive and Transportation, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3.6. Supply Chain and Logistics, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3.7. Government and Public Safety, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3.8. Agriculture, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3.9. Others, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
Company Profile
Johnson & Johnson, Inc. (U.S.),
Merck & Co. Inc. (U.S.),
Novartis AG (Switzerland),
Bayer AG (Germany),
3M Company (U.S.),
F. Hoffmann-La Roche (Switzerland),
Becton, Dickinson and Company (U.S.),
GlaxoSmithKline (U.K.),
Pfizer, Inc. (U.S.), Antares Pharma (U.S.),
and Sanofi (France).
Consultant Recommendation
**The above-given segmentations and companies could be subjected to further modification based on in-depth feasibility studies conducted for the final deliverable.
Reviews
There are no reviews yet.